Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Prognostic factors in nasopharyngeal carcinoma with synchronous liver metastasis: a retrospective study for the management of treatment.

Tian YM, Zeng L, Wang FH, Liu S, Guan Y, Lu TX, Han F.

Radiat Oncol. 2013 Nov 19;8:272. doi: 10.1186/1748-717X-8-272.

2.

Retrospective analysis of 234 nasopharyngeal carcinoma patients with distant metastasis at initial diagnosis: therapeutic approaches and prognostic factors.

Zeng L, Tian YM, Huang Y, Sun XM, Wang FH, Deng XW, Han F, Lu TX.

PLoS One. 2014 Sep 23;9(9):e108070. doi: 10.1371/journal.pone.0108070. eCollection 2014.

3.

Baseline serum lactate dehydrogenase levels for patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma: a predictor of poor prognosis and subsequent liver metastasis.

Zhou GQ, Tang LL, Mao YP, Chen L, Li WF, Sun Y, Liu LZ, Li L, Lin AH, Ma J.

Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e359-65. doi: 10.1016/j.ijrobp.2011.06.1967. Epub 2011 Oct 12. Erratum in: Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):213.

PMID:
22000748
4.

[Prognosis analysis of nasopharyngeal carcinoma patients with distant metastasis].

Wang CT, Cao KJ, Li Y, Xie GF, Huang PY.

Ai Zheng. 2007 Feb;26(2):212-5. Chinese.

PMID:
17298756
6.

Prognostic features and treatment outcome in locoregionally advanced nasopharyngeal carcinoma following concurrent chemotherapy and radiotherapy.

Cheng SH, Jian JJ, Tsai SY, Chan KY, Yen LK, Chu NM, Tan TD, Tsou MH, Huang AT.

Int J Radiat Oncol Biol Phys. 1998 Jul 1;41(4):755-62.

PMID:
9652835
7.
8.

Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.

Ozyar E, Gurkaynak M, Yildiz F, Atahan IL.

Radiother Oncol. 2004 Jul;72(1):71-7.

PMID:
15236877
9.

Prognostic value of tumor volume for patients with nasopharyngeal carcinoma treated with concurrent chemotherapy and intensity-modulated radiotherapy.

Wu Z, Su Y, Zeng RF, Gu MF, Huang SM.

J Cancer Res Clin Oncol. 2014 Jan;140(1):69-76. doi: 10.1007/s00432-013-1542-x. Epub 2013 Oct 31.

PMID:
24173695
10.

Risk subset of the survival for nasopharyngeal carcinoma patients with bone metastases: who will benefit from combined treatment?

Cao X, Han Y, He L, Xiang J, Wen Z.

Oral Oncol. 2011 Aug;47(8):747-52. doi: 10.1016/j.oraloncology.2011.05.010. Epub 2011 Jun 12.

PMID:
21665523
11.

Locoregional radiotherapy in patients with distant metastases of nasopharyngeal carcinoma at diagnosis.

Chen MY, Jiang R, Guo L, Zou X, Liu Q, Sun R, Qiu F, Xia ZJ, Huang HQ, Zhang L, Hong MH, Mai HQ, Qian CN.

Chin J Cancer. 2013 Nov;32(11):604-13. doi: 10.5732/cjc.013.10148.

12.

Partial hepatectomy for liver metastases from nasopharyngeal carcinoma: a comparative study and review of the literature.

Huang J, Li Q, Zheng Y, Shen J, Li B, Zou R, Wang J, Yuan Y.

BMC Cancer. 2014 Nov 7;14:818. doi: 10.1186/1471-2407-14-818. Review.

13.

[Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].

Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX.

Ai Zheng. 2006 Dec;25(12):1543-9. Chinese.

PMID:
17166383
14.

Comparing treatment outcomes of different chemotherapy sequences during intensity modulated radiotherapy for advanced N-stage nasopharyngeal carcinoma patients.

Sun X, Zeng L, Chen C, Huang Y, Han F, Xiao W, Liu S, Lu T.

Radiat Oncol. 2013 Nov 13;8:265. doi: 10.1186/1748-717X-8-265.

15.

The prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma.

Lee CC, Chu ST, Chou P, Lee CC, Chen LF.

Clin Otolaryngol. 2008 Oct;33(5):442-9. doi: 10.1111/j.1749-4486.2008.01770.x.

PMID:
18983377
16.

Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.

Han L, Lin SJ, Pan JJ, Chen CB, Zhang Y, Zhang XC, Liao XY, Chen QS.

Chin J Cancer. 2010 Feb;29(2):145-50.

17.

Prognosticators and risk grouping in patients with lung metastasis from nasopharyngeal carcinoma: a more accurate and appropriate assessment of prognosis.

Cao X, Luo RZ, He LR, Li Y, Lin WQ, Chen YF, Wen ZS.

Radiat Oncol. 2011 Aug 26;6:104. doi: 10.1186/1748-717X-6-104.

18.

Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group.

Yu KH, Leung SF, Tung SY, Zee B, Chua DT, Sze WM, Law SC, Kam MK, Leung TW, Sham JS, Lee AW, Au JS, Hui EP, Sze WK, Cheng AC, Yau TK, Ngan RK, Wong FC, Au GK, Chan AT; Hong Kong Nasopharyngeal Carcinoma Study Group.

Head Neck. 2005 May;27(5):397-405.

PMID:
15726589
19.

Increased lymphocyte to monocyte ratio is associated with better prognosis in patients with newly diagnosed metastatic nasopharyngeal carcinoma receiving chemotherapy.

Lin GN, Peng JW, Liu DY, Xiao JJ, Chen YQ, Chen XQ.

Tumour Biol. 2014 Nov;35(11):10849-54. doi: 10.1007/s13277-014-2362-6. Epub 2014 Aug 1.

PMID:
25081376
20.

Prognostic factors and outcome for nasopharyngeal carcinoma.

Farias TP, Dias FL, Lima RA, Kligerman J, de Sá GM, Barbosa MM, Gonçalves FB Jr.

Arch Otolaryngol Head Neck Surg. 2003 Jul;129(7):794-9.

PMID:
12874084
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk